Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases

Chemical Engineering Science

Volumn 58, Issue 18, 2003, Pages 4087-4114

  Feng, Si Shen ^a   Chien, Shu ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biodegradable polymers; Controlled release; Drug delivery; Liposomes; Micelles; Nanoparticles; Targeted delivery

Indexed keywords

BIOCHEMICAL ENGINEERING; BIOMEDICAL ENGINEERING; CARDIOVASCULAR SYSTEM; CELL MEMBRANES; DISEASES; HEALTH CARE; LIPIDS; ONCOLOGY; POLYMERS; TUMORS;

DRUG DELIVERY SYSTEMS;

CHEMOTHERAPY;

MEDICAL APPLICATION;

EID: 0141676399     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2509(03)00234-3     Document Type: Review

References (335)

1. Adler M. Unger M. Lee G. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant Pharmaceutical Research 17 7 2000 863-870
2. Ahsan F.L. Rivas I.P. Khan M.A.et al. Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages Journal of Controlled Release 79 1-3 2002 29-40
3. Allemann E. Leroux J.C. Gurnay R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetrics Advances in Drug Delivery Reviews 34 2-3 1998 171-189
4. Allemann E. Leroux J.C. Gurnay R. Doelker E. In vitro extended-release properties of drug-loaded poly(,-lactic) acid nanoparticles produced by a salting-out procedure Pharmaceutical Research 10 1993 1732-1737
5. Allen T.M. Liposomes-opportunities in drug delivery Drugs 54 4 1997 8-14
6. Alyautdin R. Gothier D. Petrov V. Kharkevich D.A. Kreuter J. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles European Journal of Pharmaceutics and Biopharmaceutics 41 1995 44-48
7. Alyautdin R.N. Petrov V.E. Langer K. Berthold A. Kharkevich D.A. Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles Pharmaceutical Research 14 1997 325-328
8. Alyaudtin R.N. Reichel A. Lobenberg R.et al. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro Journal of Drug Targeting 9 3 2001 209
9. Alyautdin R.N. Tezikov E.B. Ramge P. Kharkevich D.A. Begley D.J. Kreuter J. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study Journal of Microencapsulation 15 1998 67-74
10. American Cancer Society, . (2002a). Cancer Facts - Figures 2002.
11. American Cancer Society, . (2002b). Cancer Prevention - Early Detection, Facts and Figures 2002.
12. Au J.L.S. Jang S.H. Wientjes M.G. Clinical aspects of drug delivery to tumors Journal of Controlled Release 78 1-3 2002 81-95
13. Au J.L.S. Jang S.H. Zheng J.et al. Determinants of drug delivery and transport to solid tumors Journal of Controlled Release 74 1-3 2001 31-46
14. Aveyard R. Clint J.H. Nees D.et al. Compression and structure of monolayers of charged latex particles at air/water and octane/water interfaces Langmuir 16 2000 1969-1979
15. Baban D. Seymour L.W. Control of tumor vascular permeability Advanced Drug Delivery Reviews 34 1998 109-119
16. Banerjee G. Nandi G. Mahato S.B.et al. Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes Journal of Antimicrobial Chemotherapy 38 1 1996 145-150
17. Banerjee T. Mitra S. Singh A.K.et al. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles International Journal of Pharmaceutics 243 1-2 2002 93-105
18. Bangham A.D. Surrogate cells or Trojan horses. The discovery of liposomes Bioessays 17 1995 1081-1088
19. Bangham A.D. Horne R.W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope Journal of Molecular Biology 8 1964 660-668
20. Bawa R. Siegel R. Marasca B. Karel M. Langer R. An explanation for the sustained release of macromolecules from polymers Journal of Controlled Release 1 1985 259-267
21. Baxter L.T. Jain R.K. Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: Comparison with experimental data British Journal of Cancer 73 4 1996 447-456
22. Behan N. Birkinshaw C. Clarke N. A study of the factors affecting the formation of poly(n-butylcyanoacrylate) nanoparticles Proceedings of the International Symposium on Controlled Release of Bioactive Materials 26 1999 1134-1135
23. Behan N. Birkinshaw C. Clarke N. Poly n-butyl cyanoacrylate nanoparticles: A mechanistic study of polymerisation and particle formation Biomaterials 22 11 2001 1335-1344
24. Behrens I. Pena A.I.V. Alonso M.J.et al. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport Pharmaceutical Research 19 8 2002 1185-1193
25. Beil D.R. Wein L.M. Sequencing surgery, radiotherapy and chemotherapy: Insights from a mathematical analysis Breast Cancer Research and Treatment 74 3 2002 279-286
26. Binks B.P. Particles as surfactant-similarities and differences Current Opinion in Colloid - Interface Science 7 2002 21-41
27. Bittner B. Mader K. Kroll C.et al. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: Influence of gamma-irradiation on radical formation and polymer degradation Journal of Controlled Release 59 1 1999 23-32
28. Boudad H. Legrand P. Appel M.et al. Formulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir Stp Pharma Sciences 11 5 2001 369-375
29. Brigger I. Dubernet C. Couvreur P. Nanoparticles in cancer therapy and diagnosis Advanced Drug Delivery Reviews 54 5 2002 631-651
30. Bruck A. Abu-Dahab R. Borchard G.et al. Lectin-functionalized liposomes for pulmonary drug delivery: Interaction with human alveolar epithelial cells Journal of Drug Targeting 9 4 2001 241
31. Butler M. Animal cell culture and technology 1996 IRL Press Oxford
32. Calabresi, P., - Schein, P. S. (1993). Medical oncology: Basic principles and clinical management of cancer (2nd ed.). Health Professions Division, New York: McGraw-Hill.
33. Calvo P. Remunan-Lopez C. Vila-Jato J.L. Alonso M.J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines Pharmaceutical Research 14 1997 1431-1436
34. Campbell R.B. Balasubramanian S.V. Straubinger R.M. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes Journal of Pharmaceutical Sciences 90 8 2001 1091-1105
35. Carmeliet P. Jain R.K. Angiogenesis in cancer and other diseases Nature 407 6801 2000 249-257
36. Cascone M.G. Lazzeri L. Carmignani C.et al. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate Journal of Materials Science-Materials in Medicine 13 5 2002 523-526
37. Cavalli F. Hansen H.H. Kaye S.B. Textbook of medical oncology 1997 Martin Dunitz London
38. Ceruti M. Crosasso P. Brusa P.et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel Journal of Controlled Release 63 1-2 2000 141-153
39. Chan M.S. Montresor A. Savioli L.et al. Planning chemotherapy based schistosomiasis control: Validation of a mathematical model using data on Schistosoma haematobium from Pemba, Tanzania Epidemiology and Infection 123 3 1999 487-497
40. Chang H.C. Li L.C. Sustained-release butorphanol microparticles Drug Development and Industrial Pharmacy 26 8 2000 829-835
41. Chen D.B. Yang T.Z. Lu W.L.et al. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel Chemical - Pharmaceutical Bulletin 49 11 2001 1444-1447
42. Chiannilkulchai N. Driouich Z. Benoit J.P.et al. Doxorubicin nanoparticles, colloidal drug carriers for treatment of hepatic metastases in animals Bulletin on Cancer 76 8 1989 845-848
43. Chiannilkulchai N. Driouich Z. Benoit J.P.et al. Doxorubicin-loaded nanoparticles-increased efficiency in murine hepatic metastases Selective Cancer Theropeutics 5 1 1989 1-11
44. Chorny M. Fishbein I. Golomb G. Drug delivery systems for the treatment of restenosis crc Critical Reviews in Therapeutic Drug Carrier Systems 17 3 2000 249-284
45. Chrai S.S. Murari R. Ahmad I. Liposomes (a review)-Part two: Drug delivery systems Biopharm-the Applied Technologies of Bioopharmaceutical development 15 1 2002 40
46. Christina R.H. Danishefsky S.J. Complex target-oriented synthesis in the drug discovery process: A case history in the dEpoB series Journal of Organic Chemistry 64 1999 8434-8456
47. Clare S.E. Nakhlis F. Panetta J.C. Molecular biology of breast cancer metastasis-The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer Breast Cancer Research 2 6 2000 430-435
48. Clint J.H. Taylor S.E. Particle size and interparticle forces of overbased detergents: A Langmuir trough study Colloids and Surfaces 65 1992 61-67
49. Coester C. Kreuter J. von Briesen H.et al. Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA) International Journal of Pharmaceutics 196 2 2000 147-149
50. Coester C.J. Langer K. Von Briesen H.et al. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake Journal of Microencapsulation 17 2 2000 187-193
51. Couvreur P. Kante B. Roland M. Goit P. Bauduin P. Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: Preparation, morphology and sorptive properties Journal of Pharmacy and Pharmacology 31 1979 331-332
52. Crosasso P. Ceruti M. Brusa P.et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes Journal of Controlled Release 63 1-2 2000 19-30
53. Cui Z.R. Mumper R.J. Chitosan-based nanoparticles for topical genetic immunization Journal of Controlled Release 75 3 2001 409-419
54. Das G.S. Rao G.H.R. Wilson R.F.et al. Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres Journal of Biomedical Materials Research 55 1 2001 96-103
55. Dass C.R. Burton M.A. Microsphere-mediated targeted gene therapy of solid tumors Drug Delivery 6 4 1999 243-252
56. Davda J. Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells International Journal of Pharmaceutics 233 1-2 2002 51-59
57. Davis S.C. Szoka F.C. Conditionally stable liposomes for drug delivery Abstracts of Papers of the American Chemical Society 213 PMSE Part 2 1997 304
58. De T.K. Hoffman A.S. A reverse microemulsion polymerization method for preparation of bioadhesive polyacrylic acid nanoparticles for mucosal drug delivery: Loading and release of timolol maleate Artifical Cells Blood Substitutes and Immobilization Biotechnology 29 1 2001 31-46
59. De Campos A.M. Sanchez A. Alonso M.J. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin International Journal of Pharmaceutics 224 1-2 2001 159-168
60. De Jaeghere F. Allemann E. Feijen J.et al. Cellular uptake of PEO surface-modified nanoparticles: Evaluation of nanoparticles made of PLA : PEO diblock and triblock copolymers Journal of Drug Targeting 8 3 2000 143-153
61. De Jaeghere F. Allemann E. Leroux J.C.et al. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake Pharmaceutical Research 16 6 1999 859-866
62. Delie F. Advanced Drug Delivery Reviews 34 2-3 1998 221-233
63. Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract Advanced Drug Delivery Reviews 34 1998 221-233
64. Dellacherie E. Gref R. Quellec P.S. Nanospheres as new injectable drug carriers: A promising way? MS-Medicine Sciences 17 5 2001 619-626
65. DeMario M.D. Ratain M.J. Oral chemotherapy: Rationale and future directions Journal of Clinical Oncology 16 1998 2557-2567
66. Demoy M. Andreux J.P. Weingarten C.et al. Spleen capture of nanoparticles: Influence of animal species and surface characteristics Pharmaceutical Research 16 1 1999 37-41
67. Desai M.P. Labhasetwar V. Amidon G.L.et al. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size Pharmaceutical Research 13 12 1996 1838-1845
68. Desai M.P. Labhasetwar V. Walter E. Levy R.J. Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent Pharmaceutical Research 14 11 1997 1568-1573
69. Deverdiere A.C. Dubernet C. Nemati F.et al. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells cancer Chemotherapy and Pharmacology 33 6 1994 504-508
70. Donehower R.C. Rowinsky E.K. Grochow L.B. Longnecker S.M. Ettinger D.S. Phase I trial of Taxol in patients with advanced cancer Cancer Treatment Reports 71 1987 1171-1177
71. Dorr R.T. Pharmacology and toxicology of Cremophor EL diluent Annals of Pharmacotherapy 28 1994 S11-S14
72. Drummond D.C. Zignani M. Leroux J.C. Current status of pH-sensitive liposomes in drug delivery Progress in Lipid Research 39 5 2000 409-460
73. Dyer A.M. Hinchcliffe M. Watts P.et al. Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles Pharmaceutical Research 19 7 2002 998-1008
74. Dykstra K.H. Loewy J. Schwertschlag U.et al. A mathematical model of the kinetics of platelet production after high-dose chemotherapy and treatment with Neumega(R) (rhIL-11) Blood 90 Part 2 Suppl. 1, 10 1997 3553
75. Egea M.A. Valls O. Alsina M.A.et al. Interaction of amikacin loaded nanoparticles with phosphatidaylcholine monolayers as membrane models International Journal of Pharmaceutics 67 1991 103-112
76. Egea M.A. Alsina M.A. Espina M.et al. Penetration kinetics of cis-diamminedichloroplatinum (II) loaded nanoparticles in lipid monolayers as a membrane model of the reticuloendothelial system Thin Solid Films 210/211 1992 364-367
77. Ehrlich A. Borris D. Tejura K.et al. Intravenous micellar paclitaxel improves severe psoriasis Journal of Investigative Dermatology 119 Part 2, 1 2002 171
78. Eiseman J.L. Eddington N.D. Leslie J. MacAuley C. Sentz D.L. Zuhowski M. Kujawa J.M. Young D. Egorin M.J. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice Cancer Chemotherapy and Pharmacology 34 1994 465-471
79. El-Kareh A.W. Secomb T.W. Theoretical models for drug delivery to solid tumors crc Critical Reviews in Biomedical Engineering 25 6 1997 503-571
80. El-Kareh A.W. Secomb T.W. A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells Neoplasia 2 4 2000 325-338
81. Esposito E. Roncarati R. Cortesi R.et al. Production of Eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics Pharmaceutical Development and Technology 5 2 2000 267-278
82. Evora C. Soriano I. Rogers R.A. Shakesheff K.M. Hanes J. Langer R. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: The effect of 1,2-dipalmitoylphosphatidylcholine Journal of Controlled Release 51 1998 143-152
83. Farrugia C.A. Groves M.J. The activity of unloaded gelatin nanoparticles on murine melanoma B16-F0 growth in vivo Anticancer Research 19 2A 1999 1027-1031
84. Fenart L. Casanova A. Dehouck B.et al. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier Journal of Pharmacology and Experimental Therapeutics 291 3 1999 1017-1022
85. Feng S.S. Interpretation of mechanochemical properties of lipid monolayers at the air-water or oil-water interface and bilayer vesicles from equation of state or pressure-area measurement Langmuir 15 4 1999 998-1010
86. ®) within the lipid monolayer at the air-water interface Langmuir 18 2002 4061-4070
87. Feng S.S. Huang G.F. Effects of phospholipids as emulsifiers on controlled release of paclitaxel from nanospheres of biodegradable polymers Journal of Controlled Release 71 2001 53-69
88. Feng, S. S., Mu, L., - Win, K. Y. (2003a). Chemotherapeutic engineering: Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Current Medicinal Chemistry, in press.
89. Feng, S. S., Ruan, G., - Li, Q. T. (2003b). Liposome encapsulated microspheres of biodegradable polymers: A novel drug delivery device conceived from a combination of polymer-based and lipid-based controlled delivery systems. Pharmaceutical Research.
90. Fernandez-Urrusuno R. Calvo P. Remunan-Lopez C. Vila-Jato J.L. Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles Pharmaceutical Research 16 1999 1576-1591
91. Fernandez-Urrusuno R. Calvo P. Remunan-Lopez C.et al. Enhancement of nasal absorption of insulin using chitosan nanoparticles Pharmaceutical Research 16 10 1999 1576-1581
92. Fernandez-Urrusuno R. Romani D. Calvo P.et al. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration Stp Pharma Sciences 9 5 1999 429-436
93. Fishbein I. Chorny M. Banai S.et al. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model Arteriosclerosis Thrombosis and Vascular Biology 21 9 2001 1434-1439
94. Fishbein I. Chorny M. Rabinovich L.et al. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis Journal of Controlled Release 65 1-2 2000 221-229
95. Fjallskog M.L. Frii L. Bergh J. Is cremophor, solvent for paclitaxel, cytotoxic? Lancet 342 1993 876
96. Florence A.T. Hillery A.M. Hussain N.et al. Nanoparticles as carriers for oral peptide absorption-studies on particle uptake and fate Journal of Controlled Release 36 1-2 1995 39-46
97. Fonseca C. Simoes S. Gaspar R.E. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity Journal of Controlled Release 83 2 2002 273-286
98. Fujita H. Okamoto M. Takao A. Mase H. Kojima H. Pharmacokinetics of paclitaxel in experimental animals Blood levels, Gan to Kagaku Ryoho 21 Part 1 1994 653-658
99. Gabizon A. Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy Cancer Investigation 19 4 2001 424-436
100. Gabizon A. Goren D. Horowitz A.T.et al. Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals Advanced Drug Delivery Reviews 24 2-3 1997 337-344
101. Gaspar R. Preat V. Roland M. Nanoparticles of polyisohexylcyanoacrylate (PIHCA) as carriers of primaquine-formulation, physicochemical characterization and acute toxicity International Journal of Pharmaceutics 68 1-3 1991 111-119
102. Gatmaitan Z.C. Arias I.M. Structure and function of P-glycoprotein in normal liver and small intestine Advances in Pharmacology 24 1993 77-97
103. Gelderblom H. Verweij J. Nooter K.et al. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation European Journal of Cancer 37 13 2001 1590-1598
104. Gelperina S.E. Khalansky A.S. Skidan I.N.et al. Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma Toxicology Letters 126 2 2002 131-141
105. Gerasimov O.V. Qualls M. Rui Y.et al. Intracellular drug delivery using pH- and light-activated diplasmenylcholine liposomes Abstracts of Papers of the American Chemical Society 213 PMSE Part 2 1997 303
106. Go M.L. Feng S.S. Interaction of halofantrine with phospholipid monolayers Chemical - Pharmaceutical Bulletin 49 7 2001 871-876
107. Gong K. Feng S.S. Chew J. Zhao L. Molecular interactions between lipid and paclitaxel within cell membrane simulated by the lipid monolayer at the air-water interface Medical Physics 27 6 2000 1419
108. Gong K. Feng S.S. Go M.L. Effects of pH on the stability and compressibility of DPPC/cholesterol monolayers at the air/water interface Colloids and Surfaces A-physicochemical and Engineering Aspects 207 1-3 2002 113-125
109. Gray J.W. Pallavicini M.G. Ara-C scheduling: Theoretical and experimental considerations Medical and Pediatric Oncology 10 1 1982 93-100
110. Grebe R. Danna S. Nishiwaki H.et al. Pharmacokinetics of heat-sensitive liposomes for laser targeted drug delivery Investigative Ophthalmology - Visual Science 38 Part 2, 4 1997 5222
111. Gregoriadis G. The carrier potential of liposomes in biology and medicine New England Journal of Medicine 295 1976 765-770
112. Gutman R.L. Peacock G. Lu D.R. Targeted drug delivery for brain cancer treatment Journal of Controlled Release 65 1-2 2000 31-41
113. Guzman L.A. Labhasetwar V. Song C.X.et al. Local intraluminal infusion of biodegradable polymeric nanoparticles-A novel approach for prolonged drug delivery after balloon angioplasty Circulation 94 6 1996 1441-1448
114. Harashima H. Yamane C. Kume Y.et al. Kinetic-analysis of auc-dependent saturable clearance of liposomes-mathematical-description of auc-dependency Journal of Pharmacokinetics and Biopharmaceutics 21 3 1993 299-308
115. He P. Davis S.S. Illum L. Chitosan microspheres prepared by spray drying International Journal of Pharmaceutics 187 1 1999 53-65
116. Heiati H. Tawashi R. Phillips N.C. Solid lipid nanoparticles as drug carriers II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice International Journal of Pharmaceutics 174 1-2 1998 71-80
117. Heiati H. Tawashi R. Shivers R.R.et al. Solid lipid nanoparticles as drug carriers: Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate International Journal of Pharmaceutics 146 1 1997 123-131
118. Helfrich W. Physics Letters 50A 2 1974 115-116E
119. Hennies P.T. Correia C.R.D. Santana M.H.C. Polymerization and stability of liposomes for controlled drug delivery applications Journal of Controlled Release 72 1-3 2001 275-278
120. Henrytoulme N. Decout A. Lalanne J.et al. Probing the interactions of the anticancer drug doxorubicin with polymeric nanoparticles using fluorescence spectroscopy Journal of Colloid Interface Science 162 1 1994 236-243
121. Hillery A.M. Supramolecular lipidic drug delivery systems: From laboratory to clinic-A review of the recently introduced commercial liposomal and lipid-based formulations of Amphotericin B Advanced Drug Delivery Reviews 24 2-3 1997 345-363
122. Hillery A.M. Jani P.U. Florence A.T. Comparative, quantitative study of lymphoid and nonlymphoid uptake of 60 nm polystyrene particles Journal of Drug Target 2 2 1994 151-156
123. Hishikawa T. Kusunoki T. Tsuchiya K.et al. Application of mathematical-model to multiple-dose experimental chemotherapy for fatal murine pneumonia Antimicrobial Agents and Chemotherapy 35 6 1991 1066-1069
124. Hobbs S.K. Monsky W.L. Yuan F. Roberts W.G. Griffith L. Torchilin V.P. Jain R.K. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment Proceedings of the National Academy of Sciences of the United States of America 95 1998 4607-4612
125. Holz M. Fahr A. Compartment modeling Advanced Drug Delivery Reviews 48 2-3 2001 249-264
126. Hong M.S. Lim S.J. Oh Y.K.et al. pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system Journal of Pharmacy and Pharmacology 54 1 2002 51-58
127. Horwitz S.B. Mechanism of action of Taxol Trends in Pharmacological Sciences 13 1992 134-136
128. Hoshen M.B. Na-Bangchang K. Stein W.D.et al. Mathematical modeling of the chemotherapy of Plasmodium falciparum malaria with artesunate: Postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens Parasitology 121 Part 3 2000 237-246
129. Hoshen M.B. Stein W.D. Ginsburg H. Mathematical modelling of malaria chemotherapy: Combining artesunate and mefloquine Parasitology 124 Part 1 2002 9-15
130. Hraba T. Dolezal J. Mathematical-modeling of chemotherapy in HIV-infection Folia Biological-Prague 40 3 1994 103-111
131. Hu Y. Jiang X.Q. Ding Y.et al. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles Biomaterials 23 15 2002 3193-3201
132. Huang M. Ma Z.S. Khor E.et al. Uptake of FITC-chitosan nanoparticles by a549 cells Pharmaceutical Research 19 10 2002 1488-1494
133. Hubner B. Eckert K. Maurer H.R. Synergistic and antagonistic interactions between docetaxel and interferon-beta on growth of human breast cancer cells in vitro International Journal of Oncology 9 4 1996 625-628
134. Humphrey W.R. Erickson L.A. Simmons C.A.et al. The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries Advanced Drug Delivery Reviews 24 1 1997 87-108
135. Iliadis A. Barbolosi D. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model Computers and Biomedical Research 33 3 2000 211-226
136. Jackson T.L. Byrne H.M. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy Mathematical Biosciences 164 1 2000 17-38
137. Jähnig F. Lipid exchange between membranes Biophysical Journal 46 1984 687-694
138. Jaime, N., Delgado, J. N., - William, A. R. (Eds.) (1998). Wilson - Gisvold's textbook of organic, medicinal and pharmaceutical chemistry (10th ed.). Philadelphia: Lippincott-Raven.
139. Jain R.K. 1995 Whitaker lecture: Delivery of molecules, particles, and cells to solid tumors Annals of Biomedical Engineering 24 4 1996 457-473
140. Jain R.K. Delivery of molecular and cellular medicine to solid tumors Advanced Drug Delivery Reviews 26 2-3 1997 71-90
141. Jain R.K. Transport of molecules, particles, and cells in solid tumors Annual Reviews of Biomedical Engineering 1 1999 241-263
142. Jain R.K. Delivery of molecular and cellular medicine to solid tumors Advanced Drug Delivery Reviews 46 1-3 2001 149-168
143. Jain R.K. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy Nature Medicine 7 9 2001 987-989
144. Jain R.K. Delivery of molecular medicine to solid tumors: Lessons from in vivo imaging of gene expression and function Journal of Controlled Release 74 2001 7-25
145. Janes K.A. Fresneau M.P. Marazuela A.et al. Chitosan nanoparticles as delivery systems for doxorubicin Journal of Controlled Release 73 2-3 2001 255-267
146. Jiao Y.Y. Ubrich N. Marchand-Arvier M.et al. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits Circulation 105 2 2002 230-235
147. Johnson O.L. Cleland J.L. Lee H.J. Charmis M. Duenas E. Jaworowicz W. Shepard D. Shahzamani A. Jones A.J.S. Putney S.D. A month-long effect from a single injection of microencapsulated human growth hormone Nature Medicine 3 1996 795-799
148. Jung T. Kamm W. Breitenbach A. Kaiserling E. Xiao J.X. Kissel T. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? European Journal of Pharmaceutics and Biopharmaceutis 50 2000 147-160
149. Kabbaj M. Phillips N.C. Anticancer activity of mycobacterial DNA: Effect of formulation as chitosan nanoparticles Journal of Drug Targeting 9 5 2001 317-328
150. Kalia, Y. N., Guy, R. H. (2001). Modeling transdermal drug release. Advances in Drug Delivery Reviews 48(2-3), 159-172 JUN 11 2001.
151. Kattan J. Droz J.P. Couvreur P.et al. Phase-I Clinical-trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles Investigational New Drugs 10 3 1992 191-199
152. Kaul G. Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharmaceutical Research 19 7 2002 1061-1067
153. Khanvilkar K. Maureen D.D. Douglas R. Flanagan. Drug transfer through mucus Advanced Drug Delivery Reviews 48 2-3 2001 173-193
154. Kharkevich D. Alyautdin R. Petrov V.et al. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacylate (PBCA) nanoparticles Naunyn Schmiedebergs Archives of Pharmacology 358 Suppl. 1, 1 1998 35200
155. Kim C.K. Lim S.J. Recent progress in drug delivery systems for anticancer agents Archives of Pharmacol Research 25 3 2002 229-239
156. Knight, C. G. (Ed.) (1981). Liposomes from physical structure to therapeutic applications. Amsterdam: Elsevier.
157. Koegler W.S. Patrick C. Cima M.J.et al. Carbon dioxide extraction of residual chloroform from biodegradable polymers Journal of Biomedical Materials Research 63 5 2002 567-576
158. Kolodgie F.D. John M. Khurana C.et al. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel Circulation 106 10 2002 1195-1198
159. Kompella U.B. Koushik K. Preparation of drug delivery systems using supercritical fluid technology crc Critical Reviews in Therapeutic Drug Carrier Systems 18 2 2001 173-199
160. Kongshaug M. Cheng L.S. Moan J. Rimington C. Interaction of Cremophor-EL with human plasma International Journal of Biochemistry 23 1991 473-478
161. Kostarelos K. Emfietzoglou D. Stamatelou M. Liposome-mediated delivery of radionuclides to tumor models for cancer radiotherapy: A quantitative analysis Journal of Liposome Research 9 3 1999 407-424
162. Kozusko F. Chen P.H. Grant S.G.et al. A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A Mathematical Biosciences 170 1 2001 1-16
163. Kratz F. Schutte M.T. Anticancer metal complexes and tumour targeting strategies Cancer Journal 11 4 1998 176-182
164. Kreuter, J. (1994). Nanoparticles. Colloidal drug delivery systems (pp. 219-342). New York: Marcel Dekker.
165. Kreuter J. Alyautdin R. Kharkevich D.A. Ivanov A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) Brain Research 674 1995 171-174
166. Kreuter J. Petrov V.E. Kharkevich D.A. Alyautdin R.N. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles Journal of Controlled Release 49 1997 81-87
167. Kumar M.N.V.R. Nano and microparticles as controlled drug delivery devices Journal of Pharmaceutical Sciences 3 2 2000 234-258
168. Kumar M.N.V.R. Kumar N. Domb A.J.et al. Pharmaceutical polymeric controlled drug delivery systems Advanced Polymer Science 160 2002 45-117
169. Kurose A. Yoshida W. Yoshida M.et al. Effects of paclitaxel on cultured synovial cells from patients with rheumatoid arthritis Cytometry 44 4 2001 349-354
170. Labhasetwar V. Song C.X. Humphrey W.et al. Arterial uptake of biodegradable nanoparticles: Effect of surface modifications Journal of Pharmaceutical Sciences 87 10 1998 1229-1234
171. Labhasetwar V. Song C.X. Levy R.J. Nanoparticle drug delivery system for restenosis Advanced Drug Delivery Reviews 24 1 1997 63-85
172. Lambert G. Fattal E. Couvreur P. Nanoparticulate systems for the delivery of antisense oligonucleotides Advanced Drug Delivery Reviews 47 1 2001 99-112
173. Lambkin I. Pinilla C. Targeting approaches to oral drug delivery Expert Opinion on Biological Therapy 2 1 2002 67-73
174. Langer R. Drug delivery and targeting Nature 392 6679 1998 5-10
175. Langer R. Biomaterials in drug delivery and tissue engineering: One laboratory's experience Accounts of Chemical Research 33 2000 94-101
176. Langmuir I.J. Oil lenses on water and the nature of monomolecular expanded films Journal of Chemical Physics 1 1933 756-776
177. Lanza, R. P., Langer, R., - Chick, W. L. (1997). Principles of tissue engineering (pp. 405-427). Austin, TX: Academic Press.
178. Lasic D.D. Liposomes: From physics to applications 1993 Elsevier Amsterdam, New York
179. Lasic, D. D., - Papahadjopoulos, D., (Eds.). (1998). Medical applications of liposomes. Amsterdam: Elsevier Science.
180. Lawrence M.J. Rees G.D. Microemulsion-based media as novel drug delivery systems Advanced Drug Delivery Reviews 45 1 2000 89-121
181. Lefevre M.E. Vanderhoff J.W. Laussue J.A. Joel D.D. Experimentia 34 1978 120-122
182. Leo E. Arletti R. Forni F.et al. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles Farmaco 52 6-7 1997 385-388
183. Leo E. Vandelli M.A. Cameroni R.et al. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process International Journal of Pharmaceutics 155 1 1997 75-82
184. Lefebure S. Menager C. Cabuil V.et al. Langmuir monolayers of monodispersed magnetic nanoparticles coated with a surfactant Journal of Physical Chemistry 10 1998 2733-2738
185. Lestini B.J. Sagnella S.M. Xu Z.et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery Journal of Controlled Release 78 1-3 2002 235-247
186. Le Visage C. Couvreur P. Mysiakine E.et al. In vitro and in vivo evaluation of poly(methylidene malonate 2.1.2) microparticles behavior for oral administration Journal of Drug Targeting 9 2 2001 141
187. Li J.K. Wang N. Wu X.S. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery Journal of Pharmecutical Sciences 86 8 1997 891-895
188. Liggins R.T. Burt H.M. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations Advanced Drug Delivery Reviews 54 2 2002 191-202
189. Links M. Brown R. Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs Expert Review of Molecular Medicine 1 1999 1-21
190. Lockman, P. R., Mumper, R. J., Khan, M. A., - Allen, D. D. (2002a). Nanoparticle technology for drug delivery across the blood-brain barrier, in drug development and industrial pharmacy, vol. 28(1). New York: Dekker.
191. Lockman P.R. Mumper R.J. Khan M.A.et al. Nanoparticle technology for drug delivery across the blood-brain barrier Drug Development and Industrial Pharmacy 28 1 2002 1-13
192. Loos W.J. Szebeni J. ten Tije A.J.et al. Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel Anti-Cancer Drugs 13 7 2002 767-775
193. Lopes N.M. Adams E.G. Pitts T.W. Bhuyan B.K. Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines Cancer Chemotherapy and Pharmacology 32 3 1993 235-242
194. Lundberg B.B. Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture Anti-Cancer Drug Design 12 6 1997 503-513
195. Lutsiak M.E.C. Robinson D.R. Coester C.et al. Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro Pharmaceutical Research 19 10 2002 1480-1487
196. Ma Z.S Yeoh H.H. Lim L.Y. Formulation pH modulates the interaction of insulin with chitosan nanoparticles Journal of Pharmaceutical Science 91 6 2002 1396-1404
197. Maclean, A. L., Symonds, G., - Ward, R. (2001). Immunoliposomes as targeted delivery vehicles for cancer therapeutics (Review). International Journal of Oncology 11(2), 325-332.
198. Malingre M.M. Beijnen J.H. Rosing H.et al. The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel Anti-Cancer drugs 12 4 2001 351-358
199. Malingre M.M. Beijnen J.H. Schellens J.H.M. Oral delivery of taxanes Investigational New Drugs 19 2 2001 155-162
200. Malingre M.M. Huinink W.W.T. Duchin K.et al. Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel Anti-Cancer Drugs 12 7 2001 591-593
201. Malingre M.M. Richel D.J. Beijnen J.H.et al. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel Journal of Clinical Oncology 19 4 2001 1160-1166
202. Malingre M.M. Schellens J.H.M. van Tellingen O.et al. Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration Anti-Cancer Drug 11 10 2000 813-820
203. Malingre M.M. Terwogt J.M.M. Beijnen J.H.et al. Phase I and pharmacokinetic study of oral paclitaxel Journal of Clinical Oncology 18 12 2000 2468-2475
204. Manil L. Davin J.C. Duchenne C.et al. Uptake of nanoparticles by rat glomerular mesangial cells in-vivo and in-vitro Pharmaceutical Research 11 8 1994 1160-1165
205. Mao H.Q. Ray K. Walsh S.M. August J.T. Leong K.W. DNA-chitosan nanoparticles for the gene delivery Proceedings of the International Symposium on Controlled Release Bioactive Materials 23 1996 401-402
206. Mao H.Q. Roy K. Troung-Le V.L.et al. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency Journal of Controlled Release 70 3 2001 399-421
207. Martin R.B. Fisher M.E. Minchin R.F.et al. A mathematical-model of cancer-chemotherapy with an optimal selection of parameters Mathematical Biosciences 99 2 1990 205-230
208. Maruyama K. In vivo targeting by liposomes Biological Pharmaceutical Bulletin 23 7 2000 791-799
209. Matteucci M.L. Thrall D.E. The role of liposomes in drug delivery and diagnostic imaging: A review Veterinary Radiology - Ultrasound 41 2 2000 100-107
210. Meerum Terwogt J.M. Malingré M.M. Beijnen J.H. Ten Bokkel Huinink W.W. Rosing H Koopman F.J. Van Tellingen O. Swart M. Schellens J.H.M. Coadministration of oral cyclosporin A enables oral therapy with paclitaxel Clinical Cancer Research 5 1999 3379-3384
211. McCarron P.A. Woolfson A.D. Keating S.M. Sustained release of 5-fluorouracil from polymeric nanoparticles Journal of Pharmacy and Pharmacology 52 12 2000 1451-1459
212. McClean S. Prosser E. Meehan E. Malley D.O. Clarke N. Ramtoola Z. Brayden D. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia European Journal of Pharmaceutical Sciences 6 1998 153-163
213. McClean S. Prosser E. Meehan E.et al. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia European Journal of Pharmaceutical Sciences 6 2 1998 153-163
214. McDougall S.R. Anderson A.R.A. Chaplain M.A.J.et al. Mathematical modelling of flow through vascular networks: Implications for ibmour-induced angiogenesis and chemotherapy strategies Bulletin of Mathematical Biology 64 4 2002 673-702
215. McPhail D. Tetley L. Dufes C.et al. Liposomes encapsulating polymeric chitosan based vesicles-a vesicle in vesicle system for drug delivery International Journal of Pharmaceutics 200 1 2000 73-86
216. Mehnert W. zurMuhlen A. Dingler A.et al. Solid lipid nanoparticles-a novel carrier system for cosmetics and pharmaceutics: Drug incorporation, drug liberation, sterilisation Pharmezeutische Industrie 59 6 1997 511-514
217. Miglietta A. Cavalli R. Bocca C.et al. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel International Journal of Pharmaceutics 210 1-2 2000 61-67
218. Ministry of Health, Singapore., (2001). Annual Report 2000.
219. Mishima K. Matsuyama K. Tanabe D. Yamauchi S. Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent A.I.Ch.E. Journal 46 2000 857-865
220. Mitra A.N. Ghosh P.K. Sahoo S. Long circulating RES evading hydrophilic nanoparticles Proceedings of the International Symposium on Controlled Release of Bioactive Materials 25 1998 168-169
221. Mitra S. Gaur U. Ghosh P.C.et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier Journal of Controlled Release 74 1-3 2001 317-323
222. Morris D. Kearsley J. Williams C. Cancer: A comprehensive clinical guide 1998 Harwood Academic Publishers Australia
223. Mu L. Feng S.S. Fabrication, characterization and in vitro release of paclitaxel loaded poly(lactic-co-glycolic acid) (PLGA) nanospheres prepared by the spray dry technique with phospholipids/cholesterol as additives Journal of Controlled Release 76 2001 239-254
224. Mu L. Feng S.S. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol (R)) Journal of Controlled Release 80 1-3 2002 129-144
225. ®): PLGA nanoparticles containing vitamin E TPGS Journal of Controlled Release 86 1 2003 33-48
226. Muir C.S. Epidemiology of cancer in ethnic groups British Journal of Cancer 74 29 1996 S12
227. Mukherji G. Murthy R.S.R. Miglani B.D. Preparation and evaluation of polyglutaraldehyde nanoparticles containing 5-fluorouracil International Journal of Pharmaceutics 50 1 1989 15-19
228. Muller R.H. Mehnert W. Lucks J.S.et al. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug-delivery European Journal of Pharmaceutics and Biopharmaceutics 41 1 1995 62-69
229. Murakami H. Yoshino H. Mizobe M. Kobayashi M. Takeuchi H. Kawashima Y. Preparation of poly(,-lactide-co-glycolide) latex for surface modifying material by a double coacervation method Proceedings of the International Symposium on Controlled Release of Bioactive Materials 23 1996 361-362
230. Nagle J.F.J. Membrane Biology 27 1976 233
231. Nakada Y. Tudomi R. Sakurai K.et al. Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(L-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo International Journal of Pharmaceutics 175 1 1998 109-117
232. Narasimhan B. Mathematical models describing polymer dissolution: Consequences for drug delivery Advanced Drug Delivery Reviews 48 2-3 2001 195-210
233. Niwa T. Takeuchi H. Hino T. Kunou N. Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with poly-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior Journal of Controlled Release 25 1993 89-98
234. Nuijen B. Bouma M. Schellens J.H.M.et al. Progress in the development of alternative pharmaceutical formulations of taxanes Investigational New Drugs 19 2 2001 143-153
235. O'Connor P. Hohol M. Hunter W.et al. Micellar paclitaxel for the treatment of secondary progressive multiple sclerosis: Preliminary results of the phase 1 extension study Annals of Neurology 48 3 2000 228
236. O'Connor P.W. Lee L. Moscarello M.et al. A phase 1 study of micellar paclitaxel in the treatment of secondary progressive multiple sclerosis Annals of Neurology 46 3 1999 470
237. Oku N. Namba Y. Long-circulating liposomes crc Critical Reviews in Therapeutic Drug Carrier Systems 11 4 1994 231-270
238. Olivieri A. Offidani M. Ciniero L.et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF-proposal for a mathematical-model Bone Marrow Transplantation 14 2 1994 273-278
239. Page-Clisson M.E. Gibaud S. Pinto-Alphandary H.et al. Polyisobutylcyano-acrylate nanoparticles as drug carriers: Influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin- and doxorubicin-loaded nanoparticles International Journal of Pharmaceutics 166 1 1998 117-120
240. Panchagnula R. Pharmaceutical aspects of paclitaxel International Journal of Pharmaceutics 172 1-2 1998 1-15
241. Panetta J.C. A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment Bulletin of Mathematical Biology 58 3 1996 425-447
242. Panetta J.C. A mathematical model of breast and ovarian cancer treated with paclitaxel Mathematical Biosciences 146 2 1997 89-113
243. Panetta J.C. Adam J. A mathematical-model of cycle-specific chemotherapy Mathematical and Computer Modelling 22 2 1995 67-82
244. Parker R.S. Doyle F.J.III. Control-relevant modeling in drug delivery Advanced Drug Delivery Reviews 48 2-3 2001 211-228
245. Pazdur, R. (1995). Medical oncology: A comprehensive review (2nd ed). Huntington, NY: PRR.
246. Peppas L.B. Recent advances on the use of biodegradable microparticles and nanoparticles in the controlled drug delivery International Journal of Pharmaceutics 116 1995 1-9
247. Pietzonka P. Rothen-Rutishauser B. Langguth P.et al. Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to Caco-2 monolayers mimics particle uptake Pharmaceutical Research 19 5 2002 595-601
248. Pinto-Alphandary H. Andremont A. Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications International Journal of Antimicrobial Agents 13 3 2000 155-168
249. Powis G. Anticancer drug pharmacodynamics Cancer Chemotherapy and Pharmacology 14 1985 177-183
250. Qaddoumi M.G. Ueda H. Yang J.et al. Uptake of biodegradable nanoparticles in pigmented rabbit conjunctival epithelial cells Investigative Ophthalmology - Visual Science 41 4 2000 4054B1
251. Qaddoumi M.G. Ueda H. Yang J.et al. The mechanism of uptake of biodegradable PLGA nanoparticles in conjunctival epithelial cell layers Investigative Ophthalmology of Visual Science 42 4 2001 2628
252. Quintanar G.D. Ganem Q.A. Allemann E. Fessi H. Doelker E. Influence of the stabilizer coating layer on the purification and freeze drying of poly (-lactic acid) nanoparticles prepared by emulsification-diffusion technique Journal of Microencapsulation 15 1998 107-119
253. Randolph T.W. Randolph A.D. Mebes M. Yeung S. Sub-micron-sized biodegradable particles of poly(-lactic acid) via the gas antisolvent spray precipitation process Biotechnology Progress 9 1993 429-435
254. Ratain M.J. Schilsky R.L. Conley B.A. Egorin M.J. Pharmacodynamics in cancer therapy Journal of Clinical Oncology 8 10 1990 1739-1753
255. Redhead H.M. Davis S.S. Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterisation and in vivo evaluation Journal of Controlled Release 70 3 2001 353-363
256. Rogers J.A. Anderson K.E. The potential of liposomes in oral drug delivery crc Critical Reviews Therapeutic Drug Carrier Systems 15 5 1998 421-480
257. Rolland A. Pharmacokinetics and tissue distribution of doxorubinic-loaded polymethacrylic nanoparticles in rabbits International Journal of Pharmaceutics 42 1-3 1988 145-154
258. Rousseau V. Denizot B. Pouliquen D.et al. Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats Magnetic Resonance Materials in Physics, Biology and Medicine 5 3 1997 213-222
259. Rowinsky E.K. Cazenave L.A. Donehower R.C. Taxol: A novel investigational antimicrotubule agent Journal of National Cancer Institute 82 1990 1247-1259
260. Rowinsky E.K. Onetto N. Canetta R.M. Arguck S.G. Taxol-the 1st of the taxanes, an important new class of antitumor agents Seminars in Oncology 6 1992 646-662
261. Roy K. Mao H.Q. Lin K.Y. Huang S.K. Leong K.W. Oral immunization with DNA-chitosan nanoparticles Proceedings of the International Symposium on Controlled Release of Bioactive Materials 25 1998 348-349
262. Roy K. Mao H.Q. Huang S.K.et al. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy Nature Medicine 5 4 1999 387-391
263. Rudt S. Muller R.H. In-vitro phaocytosis assay of nanoparticles and microparticles by chemiluminescence: Uptake of differently sized surface-modified particles, and its correlation to particle properties and in-vivo distribution European Journal of Pharmaceutical Sciences 1 1 1993 31-39
264. Russell-Jones G. Utilization of the natural mechanism for vitamin B-12 uptake for the oral delivery of therapeutics European Journal of Pharmaceutics and Biopharmaceutics 42 4 1996 241-249
265. Russell-Jones G.J. Veitch H. Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells International Journal of Pharmaceutics 190 2 1999 165-174
266. Sakurai K. Nakada Y. Nakamura T.et al. Preparation and characterization of polylactide-poly(ethylene glycol)-polylactide triblock polymers and a preliminary in vivo examination of the blood circulation time for the nanoparticles made therefrom Journal of Macromolecular Science-Pure and Applied Chemistry 36 12 1999 1863-1877
267. Saltzman, M. W. (2001). Drug delivery: Engineering principles for drug therapy. Oxford: Department of Chemical Engineering, Cornell University.
268. Sanders E. Ashworth C.T. Experimental Cell Research 22 1961 137-145
269. Schabel F.M.Jr. Surgical adjuvant chemotherapy of metastatic murine tumors Cancer 40 1977 558-568
270. Scholes P.D. Coombes A.G.A. Illum L. Davis S.S. Vert M. Davies M.C. The preparation of sub-500 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery Journal of Controlled Release 25 1993 145-153
271. Schroeder U. Sabel B. Nanoparticles for BBB: Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections Brain Research 710 1996 121-124
272. Schroeder U. Sommerfeld P. Ulrich S. Sabel B. Nanoparticle technology for delivery of drugs across the blood-brain barrier Journal of Pharmaceutical Sciences 87 1998 1305-1307
273. Schwarz C. Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN) International Journal of Pharmaceutics 157 2 1997 171-179
274. Schwarz C. Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization Journal of Microencapsulation 16 2 1999 205-213
275. Schwarz C. Mehnert W. Lucks J.S.et al. Solid lipid nanoparticles (SLN) for controlled drug-delivery: Production, characterization and sterilization Journal of Controlled Release 30 1 1994 83-96
276. Sessa G. Weissmann G. Phospholipid spherules (liposomes) as a model for biological membranes Journal of Lipid Research 9 1968 310-318
277. Seymour L.W. Passive tumor targeting of soluble macromolecules and drug conjugates crc Critical Reviews in Therapeutic Drug Carrier Systems 9 1992 135-187
278. Shapiro D.M. Fugmann R.A. A role for chemotherapy as an adjunct to surgery Cancer Research 17 1957 1098-1101
279. Sharma D. Chelvi T.P. Kaur J.et al. Novel Taxol(R) formulation: Polyvinylpyrrolidone nanoparticle-encapsulated Taxol(R) for drug delivery in cancer therapy Oncology Research 8 7-8 1996 281-286
280. Sharma A. Sharma U.S. Liposomes in drug delivery: Progress and limitations International Journal of Pharmaceutics 154 2 1997 123-140
281. Sharma A. Sharma U.S. Straubinger R.M. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia Cancer Letters 107 2 1996 265-272
282. Shikata F. Tokumitsu H. Ichikawa H.et al. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer European Journal of Pharmaceutics and Biopharmaceutics 53 1 2002 57-63
283. Siepmann J. Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems Advanced Drug Delivery Reviews 48 2-3 2001 229-247
284. Siepmann J. Peppas N.A. Mathematical modeling of controlled drug delivery Advanced Drug Delivery Reviews 48 2-3 2001 137-138
285. Siepmann J. Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Advanced Drug Delivery Reviews 48 2-3 2001 139-157
286. Sihorkar V. Vyas S.P. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization Journal of Pharmaceutical Science 4 2 2001 138-158
287. Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs Current Pharmaceutical Design 5 6 1999 443-451
288. Singla A.K. Garg A. Aggarwal D. Paclitaxel and its formulations International Journal of Pharmaceutics 235 1-2 2002 179-192
289. Snowdowne K.W. Vakoula A. Swatman M.D.et al. Development of liposomes for drug delivery: Long term stability studies in vitro Journal of Dental Research 79 Sp. Iss. SI 2000 3451
290. Song C.X. Labhasetwar V. Cui X.M.et al. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model Journal of Controlled Release 54 2 1998 201-211
291. Song C.X. Labhasetwar V. Murphy H.et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery Journal of Controlled Release 43 2-3 1997 197-2121
292. Soppimatha K.S. Aminabhavi T.M. Kulkarnia A.R. Rudzinskib W.E. Biodegradable polymeric nanoparticles as drug delivery devices Journal of Controlled Release 70 1-2 2001 1-20
293. Sparreboom A. Nooter K. Does P-glycoprotein play a role in anticancer drug pharmacokinetics? Drug Resistance Update 3 6 2000 357-363
294. ®) caused by P-glycoprotein in the intestine Proceedings of the National Academy of Sciences of the United States of America 94 5 1997 2031-2035
295. Stanton L.A. Dehghani F.B. Foster N.R. Improving drug delivery using polymers and supercritical fluid technology Australian Journal of Chemistry 55 6-7 2002 443
296. Tan H.S. Borsadia S. Particle formation using supercritical fluids: Pharmaceutical applications Expert Opinion Therapeutic Patients 11 5 2001 861-872
297. Tan, K. H., Lee, T., - Wang, C. H. (2002a). Simulation of intra-tumoral release of etanidazole: Effects of the size of surgical opening. Journal of Pharmaceutical Sciences.
298. Tan, K. H., Wang, F. J., Lee, T., - Wang, C. H. (2002b). Delivery of etanidazole to brain tumor from PLGA wafers: A double burst release system. Biotechnology and Bioengineering.
299. Tedjarati S. Baker C.H. Apte S.et al. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel Clinical Cancer Research 8 7 2002 2413-2422
300. Terwogt J.M.M. Beijnen J.H. Huinink W.W.T.et al. Co-administration of cyclosporin enables oral therapy with paclitaxel Lancet 352 9124 1998 285
301. Tian X.X. Groves M.J. Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles Journal of Pharmacy and Pharmacology 51 1999 151-157
302. Tobio M. Sanchez A. Vila A.et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration Colloids and Surfaces B-Biointerfaces 18 3-4 2000 315-323
303. Tokumitsu H. Hiratsuka J. Sakurai Y.et al. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: In vivo growth suppression of experimental melanoma solid tumor Cancer Letters 150 2 2000 177-182
304. Tokumitsu H. Ichikawa H. Fukumori Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: Preparation by novel emulsion-droplet coalescence technique and characterization Pharmaceutical Research 16 12 1999 1830-1835
305. Tom J.W. Debenedetti P.G. Particle formation with supercritical fluids-a review Journal of Aerosol Science 22 1991 555-584
306. Tortora G. di Isernia G. Sandomenico C.et al. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells Cancer Research 57 22 1997 5107-5111
307. Tracqui P. Cruywagen G.C. Woodward D.E.et al. A mathematical-model of glioma growth-The effect of chemotherapy on spatiotemporal growth Cell Proliferation 28 1 1995 17-31
308. Truong-Le V.L. Mao H. Walsh S. Leong K.W. August J.T. Delivery of DNA vaccine using gelatin-DNA nanoparticles Proceedings of the International Symposium on Controlled Release Bioactive Materials 24 1997 39-40
309. Tu R.S. Tirrell M.V. Mohanty K. Peptide functionalized liposomes for targeted drug delivery Biophysics Journal 80 Part 2, 1 2001 1756
310. Unezaki S. Maruyama K. Hosoda J.I. Nagae I. Koyanagi Y. Nakata M. Ishida O. Iwatsuru M. Tsuchiya S. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy International Journal of Pharmaceutics 144 1996 11-17
311. Usher J.R. Some mathematical-models for cancer-chemotherapy Computers - Mathematics with Applications 28 9 1994 73-80
312. Van Vulpen M. Kal H.B. Taphoorn M.J.B.et al. Changes in blood-brain barrier permeability induced by radiotherapy: Implications for timing of chemotherapy? (Review) Oncology Reports 9 4 2002 683-688
313. Van Zuylen L. Nooter K. Sparreboom A.et al. Development of multidrug-resistance convertors: Sense or nonsense? Investigational New Drugs 18 3 2000 205-220
314. Van Zuylen L. Verweij J. Sparreboom A. Role of formulation vehicles in taxane pharmacology Investigational New Drugs 19 2 2001 125-141
315. Veng-Pedersen P. Noncompartmentally based pharmacokinetic modeling Advanced Drug Delivery Reviews 48 2-3 2001 265-300
316. Verdun C. Brasseur F. Vranckx H.et al. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles Cancer Chemotherapy and Pharmacology 26 1 1990 13-18
317. Volkheimer G. Advances in Pharmacology and Chemotherapy 14 1977 163-187
318. Wang C.H. Li J. Teo C.S.et al. The delivery of BCNU to brain tumors Journal of Controlled Release 61 1-2 1999 21-41
319. Wani M.C. Taylor H.L. Wall M.E. Coeggon P. McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia Journal of American Chemical Society 93 1971 2325-2327
320. Webster L. Linsenmeyer M. Millward M. Morton C. Bishop J. Woodcock D. Measurement of cremopnor EL following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype Journal of the National Cancer Institute 85 1993 1685-1690
321. Wehrle P. Magenheim B. Benita S. The Influence of process parameters on the PLA nanoparticle size distribution evaluated by means of factorial design Journal of Pharmaceutics and Biopharmaceutics 41 1995 19-26
322. Weiss R.B. DeVita V.T. Multimodal primary cancer treatment (adjuvant chemotherapy): Current results and future prospects Annals of Internal Medicine 91 1979 251-260
323. Weiss R.B. Donehower R.C. Wiernik P.H. Ohnuma T. Gralla R.J. Trump D.L. Baker R. VanEcho D.A. VonHoff D.D. Leyland-Jones B. Journal of Clinical Oncology 8 1990 1263-1268
324. Wermuth, C. G. (2002). In Camille, G (Ed.), Practice of medicinal chemistry (2nd ed). London: Academic Press.
325. Yang S.C. Ge H.X. Hu Y.et al. Doxorubicin-loaded poly(butylcyanoacrylate) nanoparticles produced by emulsifier-free emulsion polymerization Journal of Applied Polymer Science 78 3 2000 517-526
326. Yi Y.M. Yang T.Y. Pan W.M. Preparation and distribution of 5-fluorouracil I-125 sodium alginate-bovine serum albumin nanoparticles World Journal of Gastroenterology 5 1 1999 57-60
327. Yogeshvar N.K. Richard H.G. Modeling transdermal drug release Advanced Drug Delivery Reviews 48 2-3 2001 159-172
328. Yoo H.S. Lee K.H. Oh J.E.et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates Journal of Controlled Release 68 3 2000 419-431
329. Yoo H.S. Oh J.E. Lee K.H.et al. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release Pharmaceutical Research 16 7 1999 1114-1118
330. Yuan F. Dellian M. Fukumura D. Leuning M. Berk D.D. Yorchilin V.P. Jain R.K. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size Cancer Research 55 1995 3752-3756
331. Zambaux M.F. Bonneaux F. Gref R. Maincent P. Dellacherie E. Alonso M.J. Labrude P. Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by double emulsion method Journal of Controlled Release 50 1998 31-40
332. Zhao, L. Y., - Feng, S. S. (2002). Cholesterol effects on molecular interaction between paclitaxel and lipid within the lipid monolayer at the air-water interface, in preparation.
333. Zhao, L. Y., Go, M. L., - Feng, S. S. (2003). Investigation of molecular interactions between paclitaxel and DPPC by Langmuir Film Balance and Differential Scanning Calorimetry. Journal pf Pharamacutical Sciences, in press.
334. Zhou S.Y. Fleisher D. Weiner N.et al. Oral liposomes as a drug delivery system for the treatment of inflammatory bowel disease Gastroenterology 114 Part 2 Suppl. S 4 1998 G4599
335. Zur Muhlen A. Schwarz C. Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism European Journal of Pharmaceutics and Biopharmaceutics 45 2 1998 149-155